According to reports from The Financial Express, stocks trading near all-time highs might appear expensive at first glance, but the price-earnings to growth (PEG) ratio provides a different perspective. The analysis focused on companies with market capitalisation of more than ₹5,000 crore and positive PEG ratios, excluding banks, financial companies, recently listed stocks, and businesses without clear growth plans. The stocks were screened where current price after allowing for 10% upside remained above all-time high, with the final selection based on ascending order of PEG ratio.
As reported by The Financial Express, Aegis Vopak Terminals Ltd. operates 22 terminals across six ports with existing liquid storage capacity of 1.7 million cubic metres and static LPG capacity of 2,25,800 MT. The stock trades at ₹314.95, close to its all-time high of ₹317, with a P/E ratio of 128.86x compared to industry median of 71.4x, but a PEG ratio of 0.09x versus industry median of 2.02x. The company's major expansion at Jawaharlal Nehru Port Authority involves adding 3,18,100 cubic metres of liquid storage and 77,236 MT of LPG capacity, with total investment of ₹1,675 crore.
According to The Financial Express, Strides Pharma Science Ltd. supplies pharmaceutical products to more than 100 countries with manufacturing facilities in India, Italy, Kenya, and the US. The stock trades at ₹1,219.80, near its all-time high of ₹1,231.45, with P/E ratio of 19.41x versus industry median of 31.73x and PEG ratio of 0.27x compared to industry median of 0.95x. The company targets North America revenue of ₹3,598 crore by FY28 with 10 product launches planned through March 2027.
As reported by The Financial Express, Privi Speciality Chemicals Ltd. manufactures aroma and speciality chemicals with production capacity of 48,000 MT across seven facilities. The stock trades at ₹3,444.90, close to its all-time high of ₹3,785.30, with P/E ratio of 38.5x versus industry median of 28.8x and PEG ratio of 0.27x at par with industry median. The company plans to expand capacity from current 48,000 MT to 66,000 MT by September 2027 and has outlined ₹850-900 crore capex over the next three years.
According to The Financial Express, Aegis Vopak Terminals reported revenue growth of 12.4% YoY to ₹233.8 crore in Q1FY27, while Strides Pharma Science achieved revenue growth of 13% YoY to ₹1,265.4 crore. Privi Speciality Chemicals showed strong performance with revenue rising 20% YoY to ₹681.42 crore and profit surging 43.9% YoY to ₹82.8 crore. The analysis emphasizes that stocks near record highs often leave investors questioning future growth, but these companies' low PEG ratios and identifiable growth drivers suggest potential for continued earnings expansion.
